Probe set for specifically enriching RSV whole genome in respiratory tract sample, kit and application
By designing a probe set specifically enriched for the RSV whole genome and combining it with nucleic acid extraction and sequencing technologies, the stability and accuracy issues of obtaining RSV whole genome sequences from respiratory samples were resolved, achieving high-quality whole genome capture and monitoring.
Patent Information
- Application Number
- CN202511818012.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-04
- Publication Date
- 2026-01-16
AI Technical Summary
Existing technologies struggle to efficiently and stably obtain the full genome sequence of RSV from respiratory samples, especially when pathogen abundance is low and interference from impurities is present, affecting the accuracy and integrity of sequencing.
A probe set was designed to specifically enrich the RSV whole genome in respiratory tract samples. Combining nucleic acid extraction, library construction, target sequence capture and sequencing technologies, the probe hybridization achieves high sensitivity and high specificity capture, ensuring the integrity and reliability of the whole genome sequence.
It achieves high-quality capture of the entire RSV genome, has a wide range of applications, reduces interference from impurities, improves sequencing accuracy and coverage, and supports the monitoring and discovery of new RSV genotypes.
Smart Images

Figure FT_1 
Figure SMS_1 
Figure SMS_2
Abstract
Description
(I) TECHNICAL FIELD
[0001] The application relates to a probe set for specifically enriching a full genome of RSV in a respiratory tract sample, a kit and application. (II) BACKGROUND
[0002] Respiratory syncytial virus (RSV) belongs to the Orthopneumovirus genus of the Pneumoviridae family of the Mononegavirales order, has a full length of about 15.2 kb, and encodes 11 proteins, and can be divided into two subtypes A and B, and can be divided into 22 genotypes on the basis of the A subtype and 37 genotypes on the basis of the B subtype according to the characteristics of the second hypervariable region of the G gene. RSV is one of the most common pathogens of lower respiratory tract infections, and can infect all types of people, but mainly concentrates in children, the elderly and immunocompromised people and other high-risk groups. RSV is widely prevalent in the world, and in 2019, 33 million cases of RSV-related acute lower respiratory tract infections were reported worldwide, 3.6 million cases required hospitalization, and 101,400 children aged 0-60 months died of RSV-related lower respiratory tract infections, which caused great harm to the health of patients and also brought a huge medical burden to the society.
[0003] Obtaining the full genome sequence of RSV is of great significance for RSV variation monitoring, tracing, new genotype discovery, prevention and treatment, etc. High-throughput sequencing is a conventional method for obtaining the full genome sequence of a pathogen, and usually requires the purification and culture of the pathogen before sequencing. However, RSV is difficult to culture under experimental conditions, and direct sequencing of nucleic acid isolated from positive samples will face a series of problems such as low abundance of pathogens in samples, large differences in pathogen abundance in different samples, and interference of impurities in samples, making it difficult to stably obtain high-quality full genome sequences.
[0004] Targeted capture is a method for obtaining the full genome sequence of a pathogen from a sample with lower pathogen abundance, and is a sequencing method with stronger specificity and lower cost, which can enrich the relevant sequences of the target pathogen in the sample to reduce the interference of impurities on sequencing. According to different technical routes, targeted capture can be divided into methods based on multiplex PCR or probe hybridization capture, which can enrich and capture the sequences of the target pathogen, and combine high-throughput sequencing technology for sequencing, and finally obtain the full-length sequence of the pathogen in the sample through bioinformatics methods. Compared with the probe method, the multiplex PCR method does not need to perform hybridization experiments, but it is difficult to find a conserved region to design primers for viruses with more variations, and in the capture of the full genome of the pathogen, too many primers can also cause mutual influence between the primers, resulting in performance degradation.
[0005] The probe method can tolerate a certain degree of sequence variation and is more flexible in design, but has a higher requirement for the design of the probe. If the probe is not fully or evenly covered, there will be a large difference in the capture efficiency of different regions of the target sequence, thereby affecting the performance of the whole genome capture. (III) SUMMARY
[0006] The application aims to provide a probe set, a kit and an application for specifically enriching the whole genome of RSV in respiratory samples. The probe set can capture and enrich the free nucleic acid fragments of RSV A subtype and RSV B subtype in respiratory samples with high sensitivity and high specificity, thereby obtaining high-quality whole genome sequences. While fully covering the genomes of RSV A subtype and RSV B subtype, a stronger capture effect is achieved, ensuring the integrity and reliability of the obtained RSV full-length sequences.
[0007] The technical scheme adopted by the application is as follows:
[0008] In a first aspect, the application provides a probe set for specifically enriching the whole genome of RSV in respiratory samples. The nucleotide sequence of the probe set is shown in SEQ ID NO. 1-SEQ ID NO. 170.
[0009] In a second aspect, the application provides a kit for capturing and enriching the whole genome of RSV in respiratory samples, which comprises the above-mentioned probe set.
[0010] Further, the kit comprises nucleic acid extraction reagents, library construction and target sequence capture reagents, probe hybridization reagents, and target library PCR amplification reagents.
[0011] In a third aspect, the application provides an application of the probe set or the kit in enriching the whole genome of RSV in respiratory samples.
[0012] Further, the application method is as follows: (1) using nucleic acid extraction reagents to extract the nucleic acid of the sample; (2) using library construction and target sequence capture reagents to fragmentize, end-repair and add a dA tail to the extracted nucleic acid; then using TA ligation method to add a linker; after magnetic bead purification of the ligation product, performing library amplification and library purification recovery to obtain an intermediate library (fragments are 150-200 bp); (3) using the probe set and the probe hybridization reagents to perform hybridization, and obtaining target library fragments after washing; (4) using target library PCR amplification reagents to perform amplification to obtain a final library; (5) sequencing, using fastp to perform quality control on the sequencing data, using bwa-mem2 to align with the reference genome to obtain full-length sequences, using samtools to perform reads deduplication, using blast to determine the optimal reference genome and identify the subtype and genotype.
[0013] Further, steps (2), (3) and (4) preferably use a library construction and target sequence capture kit (Gene Company, KB0055048).
[0014] Further, the sample is collected from a respiratory tract, and the sample ct value is within 35.
[0015] Compared with the prior art, the present application has the following beneficial effects:
[0016] The probe set provided by the present application can capture and enrich free nucleic acid fragments of the RSV A subtype and the RSV B subtype in the respiratory tract sample with high sensitivity and high specificity, so as to obtain high-quality whole genome sequences. Compared with sequencing after purification and culture, the method of the present application can perform whole genome sequencing on the pathogen RSV which is difficult to culture, and has a wider application range. Compared with directly sequencing positive samples, the method of the present application has stronger detection target for pathogens, and is less affected by other sequences, can effectively reduce the interference of impurities and the required sample pathogen abundance for high-quality whole genome sequencing, and can obtain high-quality RSV whole genome sequences of more samples. The probe has a certain compatibility with the sequence, can better realize whole genome capture of the new genotype of RSV, and is helpful for the discovery and monitoring of the new genotype of RSV. Meanwhile, compared with flatly covering the whole genome, the probe designed in the present application adopts a partially overlapping manner, which further enhances the capture effect of RSV under the premise of ensuring whole genome coverage. (Four) Description of Drawings
[0017] Figure 1 The figure is a schematic diagram of the design and synthesis process of the RSV whole genome capture probe of the present application. (Five) Specific Embodiment
[0018] The present application will be further described below in combination with specific embodiments, but the protection scope of the present application is not limited to this:
[0019] Example 1, design and synthesis of the probe set
[0020] Download 109 RSV whole genomes sequenced in China from the Virus database of NCBI, and confirm that more than 70 of them are RSV A subtype whole genomes and more than 35 are RSV B subtype whole genomes after identification; remove redundant sequences according to 98% similarity for the RSV A subtype and the RSV B subtype, respectively, to obtain representative sequences; then integrate the representative sequences of the RSV A subtype and the RSV B subtype, perform clustering analysis using clustal, retain the highest frequency of bases for each site to obtain consensus sequences, and name them as RSV AB.
[0021] Based on RSVAB, considering that the effective capture sequence length of the probe is greater than the probe length, combined with the statistics of the historical data probe capture length and efficiency, a probe is designed in a way of every 90bp and partial overlap, so that the probe can completely cover the entire RSV genome while enhancing the capture effect of RSV, ensuring high coverage of the sequencing results on the RSV genome, thereby obtaining high-quality RSV full-length sequence, the probe length is 120bp, and the starting position and ending position of the probe on RSVAB are marked, and the results are shown in Table 1. Since the interval of the designed probe is less than the probe length and the template of the designed probe is the consistent sequence RSVAB of the representative sequences of RSV A subtype and RSV B subtype, the designed probe can complete full coverage of the whole genome of RSV A subtype and RSV B subtype.
[0022] Table 1, sequence number, position and sequence of the probe set
[0023]
[0024] Example 2, respiratory sample RSV whole genome capture sequencing method
[0025] The kit for respiratory sample RSV whole genome capture and enrichment containing the above-mentioned probe set comprises nucleic acid extraction reagent, library construction and target sequence capture reagent, probe hybridization reagent and target library PCR amplification reagent, and the sample is detected by the following method.
[0026] 1. Sample extraction
[0027] The respiratory sputum sample is used, and the pathogenic microorganism nucleic acid extraction kit (respiratory pathogenic microorganism DNA / RNA extraction kit (magnetic bead method), Genegene, KA0006050) is used to extract nucleic acid.
[0028] 2. Library construction
[0029] The library construction and target sequence capture kit (Genegene, KB0055048) is used for fragmentation, end repair and dA tail addition; then the linker is added by TA connection method; after magnetic bead purification of the connection product, library amplification and library purification recovery are carried out, the intermediate library fragment is 150-200bp, and the library concentration is detected by qubit quantitative detection after purification.
[0030] 3. Liquid phase hybridization capture
[0031] The capture probe set described in Table 1 and the library construction and target sequence capture kit (Genegene, KB0055048) are used for hybridization, and the target library fragment is obtained after washing.
[0032] 4. Library amplification
[0033] The target library fragments were amplified by PCR using the library construction and target sequence capture kit (GeneGenie, KB0055048) to obtain the final library.
[0034] 5. Sequencing
[0035] Double-end sequencing with read length of 150 bp was performed using the Gene+Seq-2000 platform, 5G per sample.
[0036] 6. Bioinformatics analysis
[0037] The sequencing data was quality controlled using fastp, aligned with the reference genome using bwa-mem2 to obtain full-length sequences, and reads were de-duplicated using samtools, and the optimal reference genome was determined using blast and subtypes and genotypes were identified.
[0038] Example 3, Whole genome capture experiment on respiratory tract positive samples
[0039] A total of 700 RSV respiratory tract positive samples were collected, and these samples were subjected to whole genome sequencing according to the method of Example 2. After alignment, the coverage of each sample sequencing data on the genome was calculated, and the results are shown in Table 2. The genome coverage of 648 samples reached 100%, accounting for 92.6%, the genome coverage of 660 samples reached 99.95%, accounting for 94.3%, the genome coverage of 684 samples reached 99.5%, accounting for 97.7%, and only 16 samples had genome coverage less than 99.5%, accounting for 2.3%. The results show that this method can achieve stable and high-quality whole genome capture in RSV positive respiratory tract samples, and has good robustness.
[0040] Table 2, Genome coverage statistics of whole genome capture of 700 RSV positive samples
[0041]
[0042] Example 4, Whole genome capture sequencing and qPCR comparison experiment on respiratory tract positive samples
[0043] To confirm the accuracy of RSV whole genome capture typing and performance under different RSV load, 197 samples (20 RSV A and 177 RSV B determined by the method of Example 3) were selected from the 700 samples of Example 3 for qPCR experiments. The qPCR results (Table 3) showed that among the 197 samples, 20 were RSV A and 177 were RSV B, which was consistent with the whole genome capture sequencing at a rate of 100%, indicating the high accuracy and reliability of the whole genome capture sequencing in RSV typing.
[0044] Table 3, qPCR typing results of 197 RSV positive samples
[0045]
[0046] Meanwhile, as shown in Table 4, the qPCR results showed that among the 197 RSV positive samples, 179 samples had a ct value of ≤32, of which 176 had a coverage rate of >99.5% in the whole genome capture sequencing, accounting for 98.3%; 18 samples had a ct value of 32-35, of which 18 had a coverage rate of >99.5% in the whole genome capture sequencing, accounting for 100%. This indicates that under the condition of a ct value of 35 or less, there is no significant difference in the coverage rate of the whole genome capture sequencing, i.e., the RSV whole genome capture sequencing method involved in the present application can ensure high coverage of the whole genome of RSV when the ct value of the RSV positive sample is 35 or less.
[0047] Table 4, relationship between qPCR ct value and whole genome capture sequencing coverage rate of 197 RSV positive samples
[0048]
Claims
1. A set of probes specifically enriched for the full genome of RSV in a respiratory sample, characterized in that, The probe set nucleotide sequence is shown as SEQ ID NO. 1- SEQ ID NO.
170.
2. A kit for capturing and enriching RSV full genome of respiratory tract sample, comprising the probe set of claim 1.
3. The kit of claim 2, wherein The kit comprises nucleic acid extraction reagent, library construction and target sequence capture reagent, probe hybridization reagent, target library PCR amplification reagent.
4. Use of the probe set of claim 1 or the kit of claim 2 in enriching RSV full genome in respiratory tract sample.
5. The use according to claim 4, wherein the compound is ###0002### The method of the use is: (1) extracting nucleic acid of the sample by using nucleic acid extraction reagent; (2) fragmenting, end-repairing and adding dA tail to the extracted nucleic acid by using library construction and target sequence capture reagent, and then adding adapter by using TA ligation method; (3) after magnetic bead purification of the ligation product, carrying out library amplification and library purification and recovery to obtain intermediate library; (4) carrying out hybridization by using the probe set and the probe hybridization reagent, and obtaining target library fragments after washing; (5) carrying out amplification by using target library PCR amplification reagent to obtain final library; (6) sequencing, using fastp to carry out quality control on the sequencing data, using bwa-mem2 to align with reference genome to obtain full-length sequence, using samtools to carry out reads deduplication, using blast to determine optimal reference genome and identify subtype and genotype. Steps (2), (3) and (4) use library construction and target sequence capture kit.
6. The use according to claim 5, wherein the compound is ###0002### The sample is collected from respiratory tract, and the sample ct value is within 35.
7. The use according to claim 5, wherein the compound is ###0002###
Citation Information
Patent Citations
Capture probe for rubella virus full-length genome detection and kit and application thereof
CN119040516A
Probe group and kit for capturing full-length genome of respiratory syncytial virus
CN120230885A
Liquid phase hybridization probe pool, kit and joint detection method for joint detection of multiple pathogens and drug-resistant genes
CN120843744A
Library preparation kit for respiratory virus enrichment sequencing and use method for library preparation kit
WO2024174399A1
